Our study found that the total alteration rate of the PTPN3 gene was nearly 2.2% in pan-cancer, and a variety of non-synonymous mutations of PTPN3, including missense, amplification, deep deletion, splice mutation, and truncating mutation, have been detected in different cancers. Here, PTPN3 is linked to cancer.